Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07390591 · ClinicalTrials.gov registry record
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
A clinical trial of Spinal Cord Injuries and Neurogenic Bladder, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT07390591 is a study of Spinal Cord Injuries and Neurogenic Bladder that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 60 participants, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT07390591, a study of Spinal Cord Injuries and Neurogenic Bladder, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is: 1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations. Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.
Conditions Studied
Study Locations (1)
District of Columbia
- Medstar National Rehabilitation Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06-19 |
| Est. Completion | 2027-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07390591
The ClinicalTrials.gov registry entry for NCT07390591 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.
NCT07390591 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07390591 about?
NCT07390591 is a clinical study titled "Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms". The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand t...
What is the current status of trial NCT07390591?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-06-19. Estimated completion is 2027-09.
What conditions does trial NCT07390591 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Lower Urinary Tract Dysfunction.
Who is sponsoring clinical trial NCT07390591?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07390591 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord Injury and Disease
RECRUITING
Explore more on PlainTrial
Spinal Cord Injuries
All registered trials for this condition
Neurogenic Bladder
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.